Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl

Abstract

In this long-term study, cinacalcet effectively sustained reductions in PTH for up to 3 years without increasing concentrations of serum calcium, phosphorus or calcium-phosphorus product.